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Introduction

The chosen topic to research is
Diabetes Mellitus Type II (DMII).
DMII has become a rampant
disease in the United States and is
becoming more common. The
United States has an alarming rate
of new diagnosis of DMII (Chen,
2012). One of the most
disappointing facts is that it can
be prevented. DMII is not a
disease that one has to have for a
lifetime. An important detail of
this disease is that it has so many
comorbidities. Many people in
the general population think that
they can just take a pill or take
insulin to control it. However,
even this will not be enough to
counteract the debilitating, and
possibly life ending, symptoms of
this disease.

Signs and Symptoms
There are many signs and symptoms of diabetes.
While polyuria, polydipsia, and polyphagia may be
common symptoms, they are not always all present
with DMII and can sometimes be (Scheen, 2012).
DMII symptoms often develop slowly and it’s very
possible to have the disease and not know it. Other
symptoms include fatigue, weight loss, blurred
vision, and slow healing wounds (Scheen, 2012).
Common signs and symptoms of type 2 diabetes
include fatigue, especially after eating as well as
feeling hungry even after you have just eaten.
Many people also experience polyuria as well as
polydipsia. Others experience slower wound healing
times as well as frequent infections and other skin
issues such as psoriasis. Type 2 diabetics may also
experience increased hunger. This is due to the lack
of insulin moving sugar into cells which will then
cause muscles and organs to being triggered into
thinking they are starving (D’Adamio & Capril, 2011).

Underlying and Significance of Pathophysiology
DMII is occurs when the body becomes resistant to insulin or when the pancreas stops producing enough
insulin. It is not known why this happens, but factors such as obesity and genetics can play a factor in
developing this disease (McCance & Huether, 2014). Other factors that may illicit this disease are factors such as
poor diet, increased stress, smoking, and history of or current medical conditions.
These factors lead to insufficient amounts of insulin from the beta cells in insulin resistance. Normally, the
liver will suppress glucose being released into the body. However, with insulin resistance cells are not able to
react to normal levels of insulin. This is also associated with increased breakdown of lipids and higher retention
of salt and water in the kidneys. It is important to note that not all people with insulin resistance will develop
DMII (D’Adamio & Capril, 2011). Many people will not develop DMII and have classic symptoms while others are
genetically inclined to develop the disease.
Insulin resistance is the crux of DMII. Insulin resistance happens when cells fail to normally respond to the
hormone insulin. Normally the body will release insulin in the presence of glucose in the blood stream and
utilize glucose instead of fat for energy. When insulin resistance is not present, the body will use glucose
appropriately and level will remain within normal limits. When insulin resistance is present it prevents the cells
from utilizing glucose and leads to hyperglycemia. Hyperglycemia will eventually start to impair beta cells (b
cells), in the pancreas, and cause more insulin to be produced therefore creating an even higher level of insulin
in the blood and development of DMII (McCance & Huether, 2014).

Implications of Nursing Care
.
One of the key components
in nursing care
for DMII patients is education. Education on
not only the disease and its consequences,
but education on lifestyle choices that can
help end DMII. Betterment of nutrition and
exercise are far more effective than taking
medications (D’Adamio & Capril, 2011). This
along with management of the comorbidities
while they disease is in process will be the
main talking points for nurses. While the
patient is experiencing the disease it is
important to monitor blood glucose and lab
levels. Regular follow up with the Primary
physician or clinic is key to managing and
defeating DMII.

Conclusion
DMII can be a debilitating and lethal
disease if not properly managed (McCance &
Huether, 2014). The complications of insulin
resistance and sensitivity become the
beginning of a slippery slope of a downward
health spiral. DMII does not have to be a
lifelong disease. Proper diet and exercise can
decrease the chances of this disease and help
avoid all its comorbidities.
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Obesity is one of the largest contributors to the disruptions in several functions in the body. Insulin
resistance leads to elevated levels of free fatty acids which can lead to the changes in insulin incretin and
glucagon secretion which can lead to inflammation. Inflammation of cytokines from the abdomen can
contribute to insulin resistance and can also lead to fatty liver, atherclerorsis, and dyslipidemia (De La
Heras, 2017).
The most significant change in DMII is that there is an alteration in the balance between insulin sensitivity
and insulin secretion. The change in glucose metabolism is from the fall in B-cell function which damages
the pathways of insulin sensitivity and secretion. Studies suggest that diabetes does not develop until Bcells fail completely in regard to compensation for the peripheral insulin resistance state, however, the
progressive nature of DMII indicates a progressive decline in B-cell function (Chen, 2012). This along with
the other factors including B-cell mass can affect the B cell function loss. This can be due to metabolic
changes such as insulin resistance, however, other studies suggest that pre-existing conditions as well as
genetics can play a great factor in determining risk for development of the DMII. Early onset of DMII
increases risk of mortality and other comorbidities.
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